11. Economic evaluation alongside a randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Issue 1 (February 2021) Authors: Molassiotis, Alex; Dawkins, Bryony; Longo, Roberta; Suen, Lorna KP; Cheng, Hui Lin; Mok, Tony; Hulme, Claire T; Yeo, Winnie Journal: Acupuncture in medicine Issue: Volume 39:Issue 1(2021) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey. Issue 3 (March 2015) Authors: Yatabe, Yasushi; Kerr, Keith M.; Utomo, Ahmad; Rajadurai, Pathmanathan; Tran, Van Khanh; Du, Xiang; Chou, Teh-Ying; Enriquez, Ma. Luisa D.; Lee, Geon Kook; Iqbal, Jabed; Shuangshoti, Shanop; Chung, Jin-Haeng; Hagiwara, Koichi; Liang, Zhiyong; Normanno, Nicola; Park, Keunchil; Toyooka, Shinichi; T... Journal: Journal of thoracic oncology Issue: Volume 10:Issue 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer. Issue 2 (26th November 2019) Authors: Papadimitrakopoulou, Vassiliki A.; Han, Ji‐Youn; Ahn, Myung‐Ju; Ramalingam, Suresh S.; Delmonte, Angelo; Hsia, Te‐Chun; Laskin, Janessa; Kim, Sang‐We; He, Yong; Tsai, Chun‐Ming; Hida, Toyoaki; Maemondo, Makoto; Kato, Terufumi; Jenkins, Suzanne; Patel, Sabina; Huang, Xiangning; Laus, Gianluca; Mar... Journal: Cancer Issue: Volume 126:Issue 2(2020) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations. Issue 4 (April 2016) Authors: Klughammer, Barbara; Brugger, Wolfram; Cappuzzo, Federico; Ciuleanu, Tudor; Mok, Tony; Reck, Martin; Tan, Eng Huat; Delmar, Paul; Klingelschmitt, Gaëlle; Yin, Anny‐Yue; Spleiss, Olivia; Wu, Lin; Shames, David S. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. First‐Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases. Issue 3 (March 2016) Authors: Schuler, Martin; Wu, Yi‐Long; Hirsh, Vera; O'Byrne, Kenneth; Yamamoto, Nobuyuki; Mok, Tony; Popat, Sanjay; Sequist, Lecia V.; Massey, Dan; Zazulina, Victoria; Yang, James C.‐H. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. First‐Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never‐Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 Study. Issue 3 (March 2016) Authors: Yang, James Chih‐Hsin; Srimuninnimit, Vichien; Ahn, Myung‐Ju; Lin, Chia‐Chi; Kim, Sang‐We; Tsai, Chun‐Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil Journal: Journal of thoracic oncology Issue: Volume 11:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis. (July 2019) Authors: Awad, Mark M.; Leonardi, Giulia C.; Kravets, Sasha; Dahlberg, Suzanne E.; Drilon, Alexander; Noonan, Sinead A.; Camidge, D. Ross; Ou, Sai-Hong I.; Costa, Daniel B.; Gadgeel, Shirish M.; Steuer, Conor E.; Forde, Patrick M.; Zhu, Viola W.; Fukuda, Yoko; Clark, Jeffrey W.; Jänne, Pasi A.; Mok, Tony;... Journal: Lung cancer Issue: Volume 133(2019) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. Issue 6 (20th February 2022) Authors: Passaro, Antonio; Brahmer, Julie; Antonia, Scott; Mok, Tony; Peters, Solange Journal: Journal of clinical oncology Issue: Volume 40:Issue 6(2022) Page Start: 598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer. (April 2023) Authors: Cheng, Ying; Zhou, Qing; Han, Baohui; Fan, Yun; Shan, Li; Chang, Jianhua; Sun, Si; Fang, Jian; Chen, Yuan; Sun, Jianguo; Wu, Gang; Mann, Helen; Naicker, Kirsha; Shire, Norah; Mok, Tony; de Castro, Gilberto Journal: Lung cancer Issue: Volume 178(2023) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078). (February 2021) Authors: Lu, Shun; Wang, Jie; Cheng, Ying; Mok, Tony; Chang, Jianhua; Zhang, Li; Feng, Jifeng; Tu, Hai-Yan; Wu, Lin; Zhang, Yiping; Luft, Alexander; Zhou, Jian-ying; Ma, Zhiyong; Lu, You; Hu, Chengping; Shi, Yuankai; Ying, Kejing; Zhong, Hua; Poddubskaya, Elena; Soo, Ross A Journal: Lung cancer Issue: Volume 152(2021) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗